Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zandberg

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal for Immunotherapy of Cancer|November 17, 2024
Morphine treatment restricts response to immunotherapy in oral squamous cell carcinomaLisa A McIlvried, Andre A Martel Matos, Mona M Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor OutcomesPatricia McCoon, Ying Wang, Zhongwu Lai, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2014
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P Zandberg, Sandra Rollins, Olga Goloubeva, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Laryngoscope Investigative Otolaryngology|June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasisSteven Borson, Yongli Shuai, Barton F Branstetter, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|December 7, 2022
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patientsJanielle K-A Taylor, Leila J Mady, Khalil Baddour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2026
Systemic Treatment of Thyroid Cancer: ASCO GuidelineNabil F Saba, Nofisat Ismaila, Douglas Adkins, et al.
JAMA Oncology|November 2, 2018
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical TrialLillian L Siu, Caroline Even, Ricard Mesía, et al.
Lancet (London, England)|March 15, 2024
Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trialJennifer L Steel, Charles J George, Lauren Terhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A Mascarella, Tolani F Olonisakin, Purva Rumde, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|November 17, 2024
Morphine treatment restricts response to immunotherapy in oral squamous cell carcinomaLisa A McIlvried, Andre A Martel Matos, Mona M Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor OutcomesPatricia McCoon, Ying Wang, Zhongwu Lai, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2014
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P Zandberg, Sandra Rollins, Olga Goloubeva, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Laryngoscope Investigative Otolaryngology|June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasisSteven Borson, Yongli Shuai, Barton F Branstetter, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|December 7, 2022
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patientsJanielle K-A Taylor, Leila J Mady, Khalil Baddour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2026
Systemic Treatment of Thyroid Cancer: ASCO GuidelineNabil F Saba, Nofisat Ismaila, Douglas Adkins, et al.
JAMA Oncology|November 2, 2018
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical TrialLillian L Siu, Caroline Even, Ricard Mesía, et al.
Lancet (London, England)|March 15, 2024
Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trialJennifer L Steel, Charles J George, Lauren Terhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A Mascarella, Tolani F Olonisakin, Purva Rumde, et al.
Pageof 10